NEW YORK (GenomeWeb News) – BioServe said today that it will provide its genetic testing services for NGC Medical's nutrigenomics testing business.
Under the agreement, BioServe will provide Italy's NGC Medical with its CLIA-certified genomics services, including DNA extraction, QC DNA, and control DNA for the NutriGeneCode testing service.
Beltsville, Md.-based BioServe said that it expects to process around 10,000 NutriGeneCode tests in the next year.
The NutriGeneCode test uses a saliva sample to identify 50 SNPs that are involved in cellular aging and body response, such as lipid and carbohydrate metabolism, hypertension, inflammation, oxidation, and detoxification reactions and DNA repair.
Financial terms of the agreement were not released, but BioServe said that negotiations are ongoing to "develop a more comprehensive partnership between the two companies."